VHCP Management III as of Sept. 30, 2018
Portfolio Holdings for VHCP Management III
VHCP Management III holds 13 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kalvista Pharmaceuticals (KALV) | 21.5 | $28M | 1.3M | 22.11 | |
| BioCryst Pharmaceuticals (BCRX) | 17.6 | $23M | 3.1M | 7.63 | |
| Obseva Sa | 15.8 | $21M | 1.2M | 18.03 | |
| Tricida | 15.0 | $20M | 651k | 30.55 | |
| Endocyte | 8.1 | $11M | 600k | 17.76 | |
| Kiniksa Pharmaceuticals | 6.3 | $8.4M | 328k | 25.50 | |
| Kadmon Hldgs | 6.0 | $8.0M | 2.4M | 3.34 | |
| Marinus Pharmaceuticals | 5.1 | $6.7M | 672k | 10.00 | |
| Bellerophon Therapeutics | 1.9 | $2.5M | 2.3M | 1.08 | |
| Gemphire Therapeutics | 1.4 | $1.8M | 870k | 2.06 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $894k | 50k | 17.78 | |
| Chemocentryx | 0.4 | $493k | 39k | 12.63 | |
| Constellation Pharmceticls I | 0.3 | $449k | 67k | 6.73 |
